Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1631345

Cover Image

PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1631345

Global Vitamin K2 Market Size Study by Type, Form, Application, Function, and Regional Forecasts 2022-2032

PUBLISHED:
PAGES: 285 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 4950
Printable PDF (Enterprise License)
USD 6250

Add to Cart

The Global Vitamin K2 Market is valued at approximately USD 123.13 million in 2023 and is projected to grow at an impressive compound annual growth rate (CAGR) of 13.70% over the forecast period 2024-2032. Vitamin K2, a vital nutrient essential for various physiological functions, is gaining recognition for its role in promoting bone health, cardiovascular health, and immune support. This emerging market has witnessed a surge in demand due to its inclusion in pharmaceutical products, functional foods, and dietary supplements. The increasing prevalence of osteoporosis, cardiovascular diseases, and other age-related health issues has heightened the global focus on preventive health solutions, driving the market's expansion.

The market growth is further propelled by advancements in nutritional science and a rising consumer inclination towards natural and functional ingredients. The development of innovative delivery forms such as capsules, oils, and powder has broadened the accessibility and appeal of Vitamin K2 products across various demographics. Additionally, the trend toward personalized nutrition and functional food has amplified its relevance, positioning Vitamin K2 as a critical component in health supplements and pharmaceutical formulations. However, challenges such as limited awareness about its benefits and high production costs hinder widespread adoption, underscoring the need for strategic industry initiatives.

Regionally, North America has emerged as a significant contributor to the Vitamin K2 market, attributed to its robust healthcare infrastructure and growing consumer awareness of preventive healthcare measures. Meanwhile, Europe exhibits strong growth potential due to increasing research and development activities and a rising preference for natural and plant-based ingredients in the region. The Asia-Pacific region is anticipated to register the highest growth during the forecast period, fueled by a growing aging population, urbanization, and rising disposable incomes. Emerging markets in Latin America and the Middle East & Africa also offer lucrative opportunities as awareness and adoption of health-focused products continue to rise.

Major market players included in this report are:

  • Kappa Bioscience
  • NattoPharma ASA
  • Gnosis by Lesaffre
  • Koninklijke DSM N.V.
  • Viridis BioPharma
  • Seebio Biotech
  • International Flavors & Fragrances Inc.
  • GeneFerm Biotechnology Co. Ltd.
  • Solgar Inc.
  • NOW Foods
  • Ortho Molecular Products
  • BASF SE
  • BioActives LLC
  • Life Extension
  • Healthy Origins

The detailed segments and sub-segments of the market are explained below:

By Type:

  • MK-4
  • MK-7

By Form:

  • Capsules & Tablets
  • Powder & Crystalline
  • Oils & Liquid

By Application:

  • Pharmaceutical
  • Functional Food & Beverages
  • Health Supplements

By Function:

  • Bone & Cardiovascular Health
  • Blood Health & Clotting
  • Anti-Inflammatory & Immune Support
  • Other Functions

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Years considered for the study are as follows:

  • Historical year - 2022
  • Base year - 2023
  • Forecast period - 2024 to 2032

Key Takeaways:

  • Comprehensive market estimates and forecasts for 10 years from 2022 to 2032.
  • Regional and country-level analysis for each market segment.
  • Insights into competitive dynamics, including profiles of major players.
  • Detailed segmentation and sub-segmentation for nuanced understanding.
  • Strategic recommendations for stakeholders and market entrants.
  • Analysis of demand-side and supply-side drivers shaping the market.

Table of Contents

Chapter 1. Global Vitamin K2 Market Executive Summary

  • 1.1. Global Vitamin K2 Market Size & Forecast (2022-2032)
  • 1.2. Regional Summary
  • 1.3. Segmental Summary
    • 1.3.1. By Type
    • 1.3.2. By Form
    • 1.3.3. By Application
    • 1.3.4. By Function
  • 1.4. Key Trends
  • 1.5. Recession Impact
  • 1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Vitamin K2 Market Definition and Research Assumptions

  • 2.1. Research Objective
  • 2.2. Market Definition
  • 2.3. Research Assumptions
    • 2.3.1. Inclusion & Exclusion
    • 2.3.2. Limitations
    • 2.3.3. Supply Side Analysis
      • 2.3.3.1. Availability
      • 2.3.3.2. Infrastructure
      • 2.3.3.3. Regulatory Environment
      • 2.3.3.4. Market Competition
      • 2.3.3.5. Economic Viability (Consumer's Perspective)
    • 2.3.4. Demand Side Analysis
      • 2.3.4.1. Regulatory Frameworks
      • 2.3.4.2. Technological Advancements
      • 2.3.4.3. Environmental Considerations
      • 2.3.4.4. Consumer Awareness & Acceptance
  • 2.4. Estimation Methodology
  • 2.5. Years Considered for the Study
  • 2.6. Currency Conversion Rates

Chapter 3. Global Vitamin K2 Market Dynamics

  • 3.1. Market Drivers
    • 3.1.1. Rising Prevalence of Osteoporosis and Cardiovascular Diseases
    • 3.1.2. Increasing Consumer Awareness of Preventive Healthcare
    • 3.1.3. Advancements in Nutritional Science and Product Innovation
  • 3.2. Market Challenges
    • 3.2.1. Limited Awareness About Vitamin K2 Benefits
    • 3.2.2. High Production Costs Affecting Pricing
  • 3.3. Market Opportunities
    • 3.3.1. Growing Demand in Emerging Markets
    • 3.3.2. Expansion of Functional Foods and Personalized Nutrition
    • 3.3.3. Strategic Collaborations and Partnerships

Chapter 4. Global Vitamin K2 Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model
    • 4.1.7. Porter's 5 Force Impact Analysis
  • 4.2. PESTEL Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
    • 4.2.5. Environmental
    • 4.2.6. Legal
  • 4.3. Top Investment Opportunity
  • 4.4. Top Winning Strategies
  • 4.5. Disruptive Trends
  • 4.6. Industry Expert Perspective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Vitamin K2 Market Size & Forecasts by Type 2022-2032

  • 5.1. Segment Dashboard
  • 5.2. Global Vitamin K2 Market: Type Revenue Trend Analysis, 2022 & 2032 (USD Million)
    • 5.2.1. MK-4
    • 5.2.2. MK-7

Chapter 6. Global Vitamin K2 Market Size & Forecasts by Form 2022-2032

  • 6.1. Segment Dashboard
  • 6.2. Global Vitamin K2 Market: Form Revenue Trend Analysis, 2022 & 2032 (USD Million)
    • 6.2.1. Capsules & Tablets
    • 6.2.2. Powder & Crystalline
    • 6.2.3. Oils & Liquid

Chapter 7. Global Vitamin K2 Market Size & Forecasts by Application 2022-2032

  • 7.1. Segment Dashboard
  • 7.2. Global Vitamin K2 Market: Application Revenue Trend Analysis, 2022 & 2032 (USD Million)
    • 7.2.1. Pharmaceutical
    • 7.2.2. Functional Food & Beverages
    • 7.2.3. Health Supplements

Chapter 8. Global Vitamin K2 Market Size & Forecasts by Function 2022-2032

  • 8.1. Segment Dashboard
  • 8.2. Global Vitamin K2 Market: Function Revenue Trend Analysis, 2022 & 2032 (USD Million)
    • 8.2.1. Bone & Cardiovascular Health
    • 8.2.2. Blood Health & Clotting
    • 8.2.3. Anti-Inflammatory & Immune Support
    • 8.2.4. Other Functions

Chapter 9. Global Vitamin K2 Market Size & Forecasts by Region 2022-2032

  • 9.1. North America Vitamin K2 Market
    • 9.1.1. U.S. Vitamin K2 Market
      • 9.1.1.1. Type Breakdown Size & Forecasts, 2022-2032
      • 9.1.1.2. Form Breakdown Size & Forecasts, 2022-2032
      • 9.1.1.3. Application Breakdown Size & Forecasts, 2022-2032
      • 9.1.1.4. Function Breakdown Size & Forecasts, 2022-2032
    • 9.1.2. Canada Vitamin K2 Market
      • 9.1.2.1. Type Breakdown Size & Forecasts, 2022-2032
      • 9.1.2.2. Form Breakdown Size & Forecasts, 2022-2032
      • 9.1.2.3. Application Breakdown Size & Forecasts, 2022-2032
      • 9.1.2.4. Function Breakdown Size & Forecasts, 2022-2032
  • 9.2. Europe Vitamin K2 Market
    • 9.2.1. UK Vitamin K2 Market
    • 9.2.2. Germany Vitamin K2 Market
    • 9.2.3. France Vitamin K2 Market
    • 9.2.4. Spain Vitamin K2 Market
    • 9.2.5. Italy Vitamin K2 Market
    • 9.2.6. Rest of Europe Vitamin K2 Market
  • 9.3. Asia-Pacific Vitamin K2 Market
    • 9.3.1. China Vitamin K2 Market
    • 9.3.2. India Vitamin K2 Market
    • 9.3.3. Japan Vitamin K2 Market
    • 9.3.4. Australia Vitamin K2 Market
    • 9.3.5. South Korea Vitamin K2 Market
    • 9.3.6. Rest of Asia Pacific Vitamin K2 Market
  • 9.4. Latin America Vitamin K2 Market
    • 9.4.1. Brazil Vitamin K2 Market
    • 9.4.2. Mexico Vitamin K2 Market
    • 9.4.3. Rest of Latin America Vitamin K2 Market
  • 9.5. Middle East & Africa Vitamin K2 Market
    • 9.5.1. Saudi Arabia Vitamin K2 Market
    • 9.5.2. South Africa Vitamin K2 Market
    • 9.5.3. Rest of Middle East & Africa Vitamin K2 Market

Chapter 10. Competitive Intelligence

  • 10.1. Key Company SWOT Analysis
    • 10.1.1. Kappa Bioscience
    • 10.1.2. NattoPharma ASA
    • 10.1.3. Gnosis by Lesaffre
  • 10.2. Top Market Strategies
  • 10.3. Company Profiles
    • 10.3.1. Kappa Bioscience
      • 10.3.1.1. Key Information
      • 10.3.1.2. Overview
      • 10.3.1.3. Financial (Subject to Data Availability)
      • 10.3.1.4. Product Summary
      • 10.3.1.5. Market Strategies
    • 10.3.2. Koninklijke DSM N.V.
    • 10.3.3. Viridis BioPharma
    • 10.3.4. Seebio Biotech
    • 10.3.5. International Flavors & Fragrances Inc.
    • 10.3.6. GeneFerm Biotechnology Co. Ltd.
    • 10.3.7. Solgar Inc.
    • 10.3.8. NOW Foods
    • 10.3.9. Ortho Molecular Products
    • 10.3.10. BASF SE
    • 10.3.11. BioActives LLC
    • 10.3.12. Life Extension
    • 10.3.13. Healthy Origins
    • 10.3.14. NattoPharma ASA
    • 10.3.15. Gnosis by Lesaffre

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!